CHICAGO — A 14-gene molecular assay could help predict which patients with early-stage non-small cell lung cancer will benefit from adjuvant chemotherapy, according to results of the AIM HIGH ...

An international, multicenter, prospective randomized trial of adjuvant chemotherapy for stage Ia-IIa non-small cell lung cancer identified as high-risk by a 14-gene molecular assay. Savolitinib (Savo ...

Jessie J is providing an update on her health.. The "Bang Bang" singer shared that she was diagnosed with breast cancer over two months ago and has been "in and out of tests" this year. "I was ...

A Fox TV news anchor discovered this week that he had skin cancer during a live TV segment. Mike Jerrick, co-host of "Good Day Philadelphia" on FOX29, was broadcasting a skin care segment with Dr ...

LBA8027Background: Despite advances in late-stage treatments, survival of early-stage non-small cell lung cancer (NSCLC) remains dismal, with 5-year disease free survival (DFS) ... of adjuvant ...

Source Reference: Spigel DR, et al "An international, multicenter, prospective randomized trial of adjuvant chemotherapy for stage IA-IIA non-small cell lung cancer identified as high risk by a 14 ...

At the 2025 ASCO Annual Meeting, Natera presented a pan-cancer study involving 392 patients and 2,600+ samples using Signatera Genome, a recently launched assay for clinical and research use.

Source Reference: Mountzios G, et al "Tarlatamab in small-cell lung cancer after platinum-based chemotherapy" N Engl J Med 2025; DOI: 10.1056/NEJMoa2502099.

Neoadjuvant nivolumab plus chemotherapy significantly improved pathological complete response and event-free survival in patients with resectable non–small-cell lung cancer (NSCLC) in a phase 3 ...

A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing brain cancer. Tumors became smaller after the experimental CAR T cell ...